Research and Development

Showing 15 posts of 9596 posts found.

granger_nhs

New appointments to advise ministers on proposed NHS changes

April 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, granger, reforms

The Department of Health has announced that five new members will join the Independent Reconfiguration Panel (IRP) from May. The …
stephen-williams

Venaxis appoints former Pfizer executive to Board of directors

April 19, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, venaxis, williams

Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.  

Covance opens expanded Singapore lab

April 18, 2013 Research and Development Covance

Covance has expanded its central laboratory facility in Singapore to meet growing demand for drug development services in the Asia-Pacific …
lilly_scientists

Lilly increases Alzheimer’s R&D

April 18, 2013 Research and Development, Sales and Marketing Alzheimer's, lilly

Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …

Oxford Cancer Biomarkers signs discovery deal with AstraZeneca

April 18, 2013 Research and Development AstraZeneca, Oxford Cancer Biomarkers

AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …
yoosuk

Teva-Handok names chief executive

April 17, 2013 Manufacturing and Production, Research and Development, Sales and Marketing teva-handok

Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …
lilly_corporate_hq

Lilly Phase III diabetes boost

April 17, 2013 Research and Development, Sales and Marketing diabetes, dulaglutide, lilly

Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …
Caan image

Dragon’s Den entrepreneur expands into healthcare

April 17, 2013 Medical Communications, Research and Development, Sales and Marketing Dragon's den, ab prime advantage, james caan

James Caan, one of the panel of entrepreneurs on TV’s Dragons’ Den, is to expand his business into the healthcare …

Mobilising for action in consumer healthcare

April 16, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A.T. Kearney, healthcare products, marketing

A new market of consumer-focused healthcare products is emerging to occupy the space between consumer goods and pharmaceuticals – and …
675275-nouveau-president-chef-direction-aeterna

New president and chief executive for Aeterna Zentaris

April 16, 2013 Manufacturing and Production, Research and Development, Sales and Marketing aeterna zentaris

Aeterna Zentaris has announced that David Dodd has been appointed as its president and chief executive, succeeding Juergen Engel. Dodd …

Celgene appoints new Haematology head

April 15, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, browne

Celgene has announced the appointment of Karen Browne as business unit director of Haematology, Celgene UK and Ireland. Over the …
celgene_hugin

Big pharma appointments to PhRMA Board

April 15, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA

Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …

Eisai appoints chief clinical officer

April 12, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Eisai

Eisai has announced the immediate appointment of Lynn Kramer to the newly created position of chief clinical officer of Eisai …
roche_close

Roche signs Huntington’s deal

April 10, 2013 Research and Development, Sales and Marketing Huntington's, Isis, Roche

Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …

Bristol-Myers Squibb appoints executive as another retires

April 10, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …
The Gateway to Local Adoption Series

Latest content